JK1 (FAM134B) gene and colorectal cancer: A pilot study on the gene copy number alterations and correlations with clinicopathological parameters

Experimental and Molecular Pathology

Volumn 97, Issue 1, 2014, Pages 31-36

  Kasem, Kais ^a   Gopalan, Vinod ^a   Salajegheh, Ali ^a   Lu, Cu Tai ^b   Smith, Robert A ^a   Lam, Alfred K Y ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b GOLD COAST UNIVERSITY HOSPITAL   (Australia)

Author keywords

Carcinoma; Colorectal; FAM134B; JK 1

Indexed keywords

DNA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; COHORT ANALYSIS; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE EXPRESSION; GENE IDENTIFICATION; HISTOLOGY; HUMAN; HUMAN TISSUE; JK 1 GENE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MUCINOUS ADENOCARCINOMA; NUCLEOTIDE SEQUENCE; PILOT STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME;

CARCINOMA; COLORECTAL; FAM134B; JK-1;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DNA COPY NUMBER VARIATIONS; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PILOT PROJECTS;

EID: 84901337050     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.05.001     Document Type: Article

References (25)

1. Beroukhim R.G., Getz G., Nghiemphu L., Barretina J., Hsueh T., Linhart D., Vivanco I., Lee J.C., Huang J.H., Alexander S., Du J., Kau T., Thomas R.K., Shah K., Soto H., Perner S., Prensner J., Debiasi R.M., Demichelis F., Hatton C., Rubin M.A., Garraway L.A., Nelson S.F., Liau L., Mischel P.S., Cloughesy T.F., Meyerson M., Golub T.A., Lander E.S., Mellinghoff I.K., Sellers W.R. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20007-20012.
2. Davidson G., Murphy S., Polke J., Laura M., Salih M., Muntoni F., Blake J., Brandner S., Davies N., Horvath R., Price S., Donaghy M., Roberts M., Foulds N., Ramdharry G., Soler D., Lunn M., Manji H., Davis M., Houlden H., Reilly M. Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort. J. Neurol. 2012, 259:1673-1685.
3. Edge S.B., Byrd D.R., Compton C., Fritz A.G., Greene F.L., Trotti A. American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual 2010, III:143-159. Springer-Verlag, New York. 7th edn.
4. Fatima S., Chui C.H., Tang W.K., Hui K.S., Au H.W., Li W.Y., Wong M.M., Cheung F., Tsao S.W., Lam K.Y., Beh P.S., Wong J., Law S., Srivastava G., Ho K.P., Chan A.S., Tang J.C. Transforming capacity of two novel genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal squamous cell carcinoma. Int. J. Mol. Med. 2006, 17:159-170.
5. Gopalan V., Smith R.A., Ho Y.H., Lam A.K.Y. Signet-ring cell carcinoma of colorectum: current perspectives and molecular biology. Int. J. Color. Dis. 2011, 26(2):127-133.
6. Hamilton S.R., Bosman F.T., Boffetta P., Ilyas M., Morreau H., Nakamura S.I., Qurike P., Riboli E., Sobin L.H. Carcinoma of the colon and rectum. WHO classification of tumours of the digestive system 2010, 134-146. IARC Press, Lyon, France. F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise (Eds.).
7. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
8. Hermsen M., Postma C., Baak J., Weiss M., Rapallo A., Sciutto A., Roemen G., Arends J.W., Williams R., Giaretti W., De Goeij A., Meijer G. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002, 123:1109-1119.
9. Kong M., Kim Y., Lee C. A strong synergistic epistasis between FAM134B and TNFRSF19 on the susceptibility to vascular dementia. Psychiatr. Genet. 2011, 21:37-41.
10. Kurth I. Hereditary sensory and autonomic Neuropathy Type II. GeneReviews 2010.
11. Kurth I., Pamminger T., Hennings J.C., Soehendra D., Huebner A.K., Rotthier A., Baets J., Senderek J., Topaloglu H., Farrell S.A., Nürnberg G., Nürnberg P., De Jonghe P., Gal A., Kaether C., Timmerman V., Hübner C.A. Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy. Nat. Genet. 2009, 41:1179-1181.
12. Kwong D., Lam A., Guan X., Law S., Tai A., Wong J., Sham J. Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum. Pathol. 2004, 35:309-316.
13. Lam A.K., Ong K., Ho Y.H. Colorectal mucinous adenocarcinoma: the clinicopathologic features and significance of p16 and p53 Expression. Dis. Colon Rectum 2006, 49:175-1283.
14. Lam A.K., Ong K., Giv M.J., Ho Y.H. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. Pathology 2008, 40:580-585.
15. Lam A.K., Ong K., Ho Y.H. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity. Hum. Pathol. 2008, 39:599-604.
16. Lam A.K., Ong K., Ho Y.H. hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features. Int. J. Color. Dis. 2008, 23(6):587-594.
17. Lam A.K., Saleh S., Smith R.A., Ho Y.H. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity. Hum. Pathol. 2008, 39:1229-1233.
18. Lee C., Kong M., Kim Y. A strong synergistic epistasis between FAM134B and TNFRSF19 on the susceptibility to vascular dementia. Psychiatr. Genet. 2011, 21:37-41.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
20. Maehara Y., Saeki H., Morita M. Molecular mechanisms of esophageal squamous cell carcinogenesis: clues to improve treatment outcomes. Ann. Thorac. Cardiovasc. Surg. 2010, 16:387-388.
21. Saleh S., Lam A.K., Ho Y.H. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology 2008, 40:25-30.
22. Tang J.C.O., Lam K.Y., Law S., Wong J., Srivastava G. Detection of genetic alterations in esophageal squamous cell carcinomas and adjacent normal epithelia by comparative DNA fingerprinting using inter-simple sequence repeat PCR. Clin. Cancer Res. 2001, 7:1539-1545.
23. Tang W.K., Chui C.H., Fatima S., Kok S.H., Pak K.C., Ou T.M., Hui K.S., Wong M.M., Wong J., Law S., Tsao S.W., Lam K.Y., Beh P.S., Srivastava G., Chan A.S., Ho K.P., Tang J.C. Oncogenic properties of a novel gene JK-1 located in chromosome 5p and its overexpression in human esophageal squamous cell carcinoma. Int. J. Mol. Med. 2007, 19:915-923.
24. Xu S.F., Peng Z.H., Li D.P., Qiu G.Q., Zhang F. Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer. World J. Gastroenterol. 2003, 9:1713-1718.
25. Zavoral M., Suchanek S., Majek O., Fric P., Minarikova P., Minarik M., Seifert B., Dusek L. Colorectal cancer screening: 20years of development and recent progress. World J. Gastroenterol. 2014, 20:3825-3834.